HSD17B2 and Familial prostate cancer: Consistent with the putative enzymatic activity of HSD17β2 in sex steroid hormone biosynthesis, a recent report suggested that HSD17β2 drives prostate cancer development based on clinical observations of HSD17β2 overexpression in prostate tumors [41,42].